[Somatosensory evoked potentials in patients with parkinsonism during L-dopa decarboxylase inhibitor treatment].
D000328:Adult; D000368:Aged; D002230:Carbidopa / Q000494:pharmacology* / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D005071:Evoked Potentials / Q000187:drug effects*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D012890:Sleep; D013003:Somatosensory Cortex / Q000187:drug effects*; D014851:Wakefulness
D006834:Hydrazines; D007980:Levodopa; D002262:Carboxy-Lyases; D002230:Carbidopa
Somatosensoryczne potencjały wywołane u chorych z zespołem parkinsonowskim w przebiegu leczenia L-dopa i inhibitorem dekarboksylazy